spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Highly Potent Active Pharmaceutical Ingredients (HPAPI)

Highly Potent Active Pharmaceutical Ingredients (HPAPI)

13-14 May 2019
Copthorne Tara Hotel, London, UK

SMi is delighted to announce its 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 13th-14th May 2019.

The HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in development worldwide being classified as highly potent. As a result, there is a growing demand for both pharmaceutical and contracted manufacturers to adapt to the evolving HPAPI landscape.

The event will explore current market trends, challenges of correctly assessing hazard, the use of innovative containment solutions to minimize risk and advanced manufacturing processes. In addition, the conference aims to guide attendees through novel regulatory updates for each stage of HPAPI development.

Attend this conference and join our networking platform for industry professionals to provide you with the expertise to overcome the challenges of the HPAPI industry.

How Will You Benefit?

Network and learn from leading professionals such as:

CHAIR FOR 2019 - Justin Mason-Home, Director, HPAPI Project Services Limited

KEY SPEAKERS INCLUDE:

- Dr Olindo Lazzaro, Director, Global EHS Technical Operations, AbbVie

- Dr Thomas Adam, Head of Global Quality Assurance Chemical APIs, Bayer

- Mr Peter Marshall, Associate Engineering Director, AstraZeneca

- Dr Thomas Nittoli, Director, Regeneron

- Mr Nigel Saunders, SME Containment, GSK

- Dr Jack Brown, Senior Principal Scientist, Boehringer Ingelheim

FEATURED HIGHLIGHTS:

- Interactive debate on the importance of control matrices and algorithms to ensure confidence in containment

- Mastering the fundamentals of ADC development with Regeneron

- Analysing the principals of containment designs with AstraZeneca

- Using case studies by Gedeon Richter to optimise quality risk management

View the full agenda: www.highlypotentapi.com/PMPS

Early-Bird Rates

-  BOOK BY 31ST JANUARY AND SAVE 400

-  BOOK BY 28TH FEBRUARY AND SAVE 200

-  BOOK BY 29TH MARCH AND SAVE 100

phone +44 (0)20 7827 6000
email events@smi-online.co.uk
web https://bit.ly/2QROsgw
email Copthorne Tara Hotel, London
 
Print this page
Send to a friend
   
spacer
Industry Events

Clinical Trials Europe | Partnerships, Outsourcing, Operations & Technology

27 August - 21 November 2019, Barcelona, Spain

On 19-21 November 2019, the clinical trial community's most influential stakeholders will be meeting in Barcelona to discuss the evolving landscape, honing in on what it takes to harness true value from partnerships, outsourcing, operations, technology and early clinical development, for a faster, more efficient route to market.
More info >>

White Papers

Working Towards a Standardised Identification Solution

PCI Pharma Services

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>


News and Press Releases

Phillips-Medisize Enters Agreement with Global Pharmaceutical Company to Acquire Exclusive Ownership of Patents for an Innovative Mini-tablet Dispenser

HUDSON, WI September 10, 2019 Phillips-Medisize, a Molex company, announced today an agreement with a Global Pharmaceutical Company, where Phillips-Medisize acquired exclusive ownership of patents supporting an innovative mini-tablet dispenser to accommodate the varied and customized oral dispensing needs of patients.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement